Part Details | USP DEXAMETHASONE SODIUM PHOSPHATE INJECTION
6505-00-944-4126
Alternate Parts: 1176619, 6505NCM141031, NDC00641037225, NDC00641-0372-25, NDC63323016501, NDC63323-0165-01, NDC00517490125, NDC00517-4901-25, 6505-00-944-4126, 00-944-4126, 6505009444126, 009444126
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | FEB 18, 1966 | 00-944-4126 | 31533 ( DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-944-4126
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 1176619 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM141031 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00641-0372-25 | 51968 | ELKINS-SINN INC |
| NDC63323-0165-01 | 57KZ6 | FRESENIUS KABI USA, LLC |
| NDC00517-4901-25 | 32288 | LUITPOLD PHARMACEUTICALS INCDBA OSTEOHEALTH COMPANY |
Technical Data | NSN 6505-00-944-4126
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE |
| PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
| ADMINISTRATION | P$Z$DCB$DCK$DDL ORAL, SOLUBLE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| SPECIAL FEATURES | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP; 4MG/ML; 1ML VIAL; PACKAGE OF 25; STORE AT 20 TO 25 DEG C (68 TO 77 DEG F) (USP CONTROLLED ROOM TEMPERATURE); PROTECT FROM FREEZING; SENSITIVE TO HEAT; DO NOT AUTOCLAVE; PROTECT FROM LIGHT; STORE CONTAINER IN CARTON UNTIL CONTENTS HAVE BEEN USED; WITH PRESERVATIVE |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP 4MG/ML 1ML BT 25S |